Functional SOCS1 polymorphisms are associated with variation in obesity in whites

Diabetes, Obesity and Metabolism

Volumn 11, Issue 3, 2009, Pages 196-203

  Gylvin, T ^a   Ek, J ^a,b   Nolsoe R ^a   Albrechtsen, A ^a   Andersen, G ^a   Bergholdt, R ^a   Brorsson, C ^a   Bang Berthelsen, C H ^a   Hansen, T ^a   Karlsen, A E ^a,c   Billestrup, N ^a   Borch Johnsen, K ^a,d   Jorgensen T ^e   Pedersen, O ^a,d   Mandrup Poulsen, T ^a,f   Nerup, J ^a,c   Pociot, Flemming ^a,c  

^a STENO DIABETES CENTER   (Denmark)

^b JOHN F KENNEDY INSTITUTE   (Denmark)

^c LUND UNIVERSITY   (Sweden)

^d AARHUS UNIVERSITY   (Denmark)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cytokines; Diabetes; EMSA; Insulin; Obesity; Promoter activity; SOCS

Indexed keywords

AMINO ACID; GUANINE; NUCLEAR PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; THREONINE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE TOLERANCE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PROMOTER REGION; REGULATOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 59349092716     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2008.00900.x     Document Type: Article

References (26)

1. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005; 48: 1684-1699.
2. Ueki K, Kadowaki T, Kahn CR. Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome. Hepatol Res 2005; 33: 185-192.
3. Jamieson E, Chong MM, Steinberg GR et al. Socs1 deficiency enhances hepatic insulin signaling. J Biol Chem 2005; 280: 31516-31521.
4. Brady MJ. IRS2 takes center stage in the development of type 2 diabetes. J Clin Invest 2004; 114: 886-888.
5. Alexander WS, Hilton DJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 2004; 22: 503-529.
6. Krebs DL, Hilton DJ. SOCS proteins: Negative regulators of cytokine signaling. Stem Cells 2001; 19: 378-387.
7. Ueki K, Kondo T, Kahn CR. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 2004; 24: 5434-5446.
8. Santangelo C, Scipioni A, Marselli L, Marchetti P, Dotta F. Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. Eur J Endocrinol 2005; 152: 485-489.
9. Nerup J, Pociot F. A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: Identification of new loci with evidence of interactions. Am J Hum Genet 2001; 69: 1301-1313.
10. Hakonarson H, Grant SF, Bradfield JP et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007; 448: 591-594.
11. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661-678.
12. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857-864.
13. Clausen JO, Borch-Johnsen K, Ibsen H et al. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 1996; 98: 1195-1209.
14. Hansen T, Ambye L, Grarup N et al. Genetic variability of the SUR1 promoter in relation to beta-cell function and type II diabetes mellitus. Diabetologia 2001; 44: 1330-1334.
15. Lorenzen T, Pociot F, Stilgren L et al. Predictors of IDDM recurrence risk in offspring of Danish IDDM patients. Danish IDDM Epidemiology and Genetics Group. Diabetologia 1998; 41: 666-673.
16. Pociot F, Norgaard K, Hobolth N, Andersen O, Nerup J. A nationwide population-based study of the familial aggregation of type 1 (insulin-dependent) diabetes mellitus in Denmark. Danish Study Group of Diabetes in Childhood. Diabetologia 1993; 36: 870-875.
17. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: Baseline results Inter99. Eur J Cardiovasc Prev Rehabil 2003; 10: 377-386.
18. Larsen ZM, Johannesen J, Kristiansen OP, Nerup J, Pociot F. Evidence for linkage on chromosome 4p16.1 in type 1 diabetes Danish families and complete mutation scanning of the WFS1 (Wolframin) gene. Diabet Med 2004; 21: 218-222.
19. Galsgaard ED, Gouilleux F, Groner B, Serup P, Nielsen JH, Billestrup N. Identification of a growth hormone-responsive STAT5-binding element in the rat insulin 1 gene. Mol Endocrinol 1996; 10: 652-660.
20. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434.
21. Martin ER, Kaplan NL, Weir BS. Tests for linkage and association in nuclear families. Am J Hum Genet 1997; 61: 439-448.
22. Krebs DL, Hilton DJ. A new role for SOCS in insulin action. Suppressor of cytokine signaling. Sci STKE 2003; 2003: PE6.
23. Harada M, Nakashima K, Hirota T et al. Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma. Am J Respir Cell Mol Biol 2007; 36: 491-496.
24. Hansen T, Drivsholm T, Urhammer SA et al. The BIGTT test: A novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care 2007; 30: 257-262.
25. Stumvoll M, Van Haeften T, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001; 24: 796-797.
26. Ek J, Urhammer SA, Sorensen TI, Andersen T, Auwerx J, Pedersen O. Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): Divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 1999; 42: 892-895.